New Rosacea Treatments

One of the hottest areas of interest online for rosacea sufferers is new rosacea treatments. From the industry heavyweights like Galderma, Allergan, Bayer, Valeant and Stiefel to little companies like MooGoo there is a lot of interest in the up and coming rosacea treatments. See below for the latest information about what is just over the horizon.

Recent Rosacea Blog Posts

How does Soolantra (topical ivermectin) work?

Ahead of the expected approval and launch of Galderma’s Ivermectin 1% Cream is this abstract further highlighting the credentials of topical ivermectin. How does Ivermectin exhibit superior papule and pustule clearing abilities ? Well this paper tells us that topical ivermectin is effective because of its antimicrobial, antiparasitic, antibacterial, and anti-inflammatory activities. Galderma is expected […]

Continue Reading

Actavis to trial Mirvaso competitor

An interesting development in rosacea clinical trials is the emergence of a new company called Actavis. Actavis have listed a large trial where they plan to test their Brimonidine Gel against Galderma’s recently FDA approved Brimonidine-based Mirvaso Gel. The large Phase 3 trial will compare the response after 7 days. Up to 462 patients in […]

Continue Reading

Gladskin Rosacea Cream and Gel, Staphefekt in a topical

Seeking to create products based on the recently publicised MRSA-killing topical Staphefekt are some topical creams to treat rosacea, acne, eczema and general skin irritation.

Continue Reading

Laropiprant (MK-0524) fails as a treatment for a red face

We don’t often get to see research results published that show a proposed new treatment doesn’t work. It make sense that researchers and pharmaceutical companies would rather see their research and development efforts succeed and lead only to new products. A clinical trial for MK-0524, Merck’s designation for their product known as Laropiprant, has confirmed […]

Continue Reading

Report ONRELTEA bad reactions to Canada Vigilance Program

Users of ONRELTEA in Canada who have bad reactions or `adverse events’ related to using this newly approved product are reminded in the ONRELTEA Product Monograph to report these events. The body responsible for supervising prescription drugs is the Canada Vigilance Program. The Brimonidine based topical which is available in the US as Mirvaso has […]

Continue Reading

 

Top

Subscribe to Rosacea News

Enter your email address to receive the latest news about rosacea in your inbox.